You are here

Equillium to Host Business Update Call on February 26

LA JOLLA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, will be hosting a call with shareholders and the investment community to provide a business update on Tuesday, February 26, 2019.  Daniel M. Bradbury, Equillium’s chairman and chief executive officer and other members of Equillium’s management team will participate in the call. During the call the Company plans to provide an update on its clinical development programs and corporate milestones.
Tuesday, February 19, 2019 - 16:07